Curable composition, cured body, optical article, lens, and eyeglasses

The curable composition, comprising styrene, fluorene, and hydroxyl group-containing (meth)acrylate, addresses the challenge of achieving high adhesion and refractive index in plastic lenses, resulting in thinner, lighter optical articles with improved durability and light resistance.

WO2024247799A1PCT designated stage expired Publication Date: 2024-12-05TOKUYAMA CORP
View PDF 18 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018595
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-29
Filing Date
2024-05-21
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current curable compositions for plastic lenses struggle to achieve high adhesion to laminates while maintaining a low specific gravity and high refractive index, which is essential for creating thinner, lighter optical articles like eyeglasses.

Method used

A curable composition comprising a styrene compound, a fluorene group-containing compound, and a hydroxyl group-containing (meth)acrylate, optimized with specific ratios and proportions to enhance adhesion, refractive index, and specific gravity, along with additional components like ultraviolet absorbers and photochromic compounds for improved performance.

Benefits of technology

The solution results in a cured product with high adhesion to laminates, low specific gravity, and high refractive index, suitable for producing thinner, lighter optical articles such as lenses and eyeglasses with enhanced durability and light resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024018595_05122024_PF_FP_ABST
    Figure JP2024018595_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The purpose of the present invention is to provide: a curable composition that can provide a cured body that exhibits high adhesiveness with laminates; a cured body from the curable composition; and an optical article, lens, and eyeglasses that contain the cured body. An embodiment of the present invention provides a curable composition. The curable composition comprises: at least one styrene compound selected from the group consisting of styrene and styrene derivatives; a fluorene group-containing compound represented by formula (I); and a hydroxyl group-containing (meth)acrylate. In formula (I), R33 and R34 are each independently a hydrogen atom or a methyl group.
Need to check novelty before this filing date? Find Prior Art

Description

Curable composition, cured product, optical article, lens, and eyeglasses

[0001] The present invention relates to a curable composition, a cured product, an optical article, a lens, and eyeglasses.

[0002] Spectacle lenses include glass lenses and plastic lenses. The specific gravity of plastic lenses is lighter than that of glass lenses, making them lighter. On the other hand, the refractive index of plastic lenses tends to be lower than that of glass lenses. In order to make lenses thinner, plastic lenses with a high refractive index are in demand.

[0003] The plastic lens is produced, for example, by polymerizing a curable composition containing a fluorene compound, styrene or a styrene derivative, and a radical polymerization initiator.

[0004] JP 2004-269814 A JP 2008-001777 A JP 2012-246382 A JP 2012-251032 A JP 4-325508 A

[0005] An object of the present invention is to provide a curable composition capable of realizing a cured product having high adhesion to laminates, the cured product, and optical articles, lenses, and eyeglasses each containing the cured product.

[0006] According to the present disclosure, there is provided a curable composition, which includes at least one styrene compound selected from the group consisting of styrene and styrene derivatives, a fluorene group-containing compound represented by the following formula (I), and a hydroxyl group-containing (meth)acrylate:

[0007]

[0008] In formula (I), R 31 and R 32 are each independently an alkyl group having 1 to 4 carbon atoms. 33 and R 34 are each independently a hydrogen atom or a methyl group. X and Y are each independently a linear or branched alkylene group having 1 to 4 carbon atoms. Z 1 and Z 2are each independently an aromatic carbocyclic ring having 5 to 10 carbon atoms or an alkylene group having 1 to 4 carbon atoms. 3 and Z 4 are each independently an aromatic carbon ring or an alkyl group. m+n is an integer of 0 to 20. o+q and p+r are each an integer of 0 to 4.

[0009] According to the present disclosure, a cured product is provided. The cured product is a cured product of the curable composition according to an embodiment.

[0010] According to the present disclosure, an optical article is provided. The optical article includes a cured body according to an embodiment.

[0011] According to the present disclosure, a lens is provided, the lens including an optical article according to an embodiment.

[0012] According to the present disclosure, there is provided a pair of eyeglasses, the eyeglasses including lenses according to another embodiment.

[0013] According to the present invention, it is possible to provide a curable composition capable of realizing a cured product that has high adhesion to laminates, the cured product, and optical articles, lenses, and eyeglasses that include the cured product.

[0014] 1A and 1B are cross-sectional views each showing an example of a lens according to an embodiment, and a perspective view each showing an example of eyeglasses according to an embodiment.

[0015] [Curable Composition] The curable composition according to the embodiment contains at least one styrene compound selected from the group consisting of styrene and styrene derivatives, a fluorene group-containing compound represented by the above formula (I), and a hydroxyl group-containing (meth)acrylate.

[0016] By using a curable composition containing a low specific gravity styrene compound and a high refractive index fluorene group-containing compound, a cured product with low specific gravity and high refractive index can be realized. Here, functional layers such as a hard coat layer, an anti-reflection layer, a water-repellent coat layer, a protective layer, a photochromic layer, etc., or an adhesive layer for adhering these functional layers may be provided on the surface of the plastic lens. A cured product of a curable composition containing a styrene compound and a fluorene group-containing compound may have low adhesion to these laminates. The curable composition according to the embodiment can achieve high adhesion to these laminates by further containing a hydroxyl group-containing (meth)acrylate.

[0017] The curable composition according to the embodiment will be described in detail below.

[0018] (Fluorene Group-Containing Compound) The fluorene group-containing compound is represented by the following formula (I).

[0019]

[0020] In formula (I), R 31 and R 32 are each independently an alkyl group having 1 to 4 carbon atoms. 33 and R 34 are each independently a hydrogen atom or a methyl group. 33 and R 34 In terms of compatibility with the curable composition, R is preferably a hydrogen atom. That is, the fluorene group-containing compound may be a diacrylate or a dimethacrylate, and is preferably a diacrylate. 33 and R 34 is preferably a methyl group from the viewpoint of increasing the softening point of the cured product. X and Y are each independently a linear or branched alkylene group having 1 to 4 carbon atoms. Z 1 and Z 2 are each independently an aromatic carbocyclic ring having 5 to 10 carbon atoms or an alkylene group having 1 to 4 carbon atoms. 1 and Z 2 is preferably a phenylene group. 3 and Z 4are each independently an aromatic carbocyclic ring having 5 to 8 carbon atoms or an alkyl group having 1 to 4 carbon atoms. m+n is an integer of 0 to 20. o+q and p+r are each integers of 0 to 4.

[0021] In the curable composition, the proportion of the fluorene group-containing compound is preferably 10% by mass or more, more preferably 14% by mass or more, and even more preferably 19% by mass or more, from the viewpoint of increasing the refractive index of the cured body. In order to reduce the specific gravity of the cured body, the proportion of the fluorene group-containing compound is preferably 50% by mass or less, more preferably 40% by mass or less, and even more preferably 30% by mass or less. This proportion may be 45% by mass or less.

[0022] The proportion of the fluorene group-containing compound in the curable composition can be calculated, for example, by isolating the fluorene group-containing compound from the curable composition by silica gel chromatography or the like, and measuring the weight of the obtained fluorene group-containing compound.

[0023] The fluorene group-containing compound represented by formula (I) may be a commercially available product, or may be synthesized by a known method.

[0024] (Styrene Compound) The styrene compound includes at least one selected from the group consisting of styrene and styrene derivatives.

[0025] The styrene derivative is a compound having a styrene skeleton represented by the following formula (IIA).

[0026]

[0027] Specific examples of the styrene derivative include 2-methylstyrene, 3-methylstyrene, 4-methylstyrene, α-methylstyrene, α-methylstyrene dimer, 2,4,6-trimethylstyrene, 4-tert-butylstyrene, vinylphenol, vinylthiophenol, 2-chlorostyrene, 3-chlorostyrene, 4-chlorostyrene, 3-chloromethylstyrene, 4-chloromethylstyrene, 2-bromostyrene, 3-bromostyrene, 4-bromostyrene, 3-bromomethylstyrene, 4-bromomethylstyrene, 4-aminostyrene, 3-cyanomethylstyrene, 4-cyanomethylstyrene, divinylbenzene, trivinylbenzene, 4-vinylbiphenyl, 2,2'-divinylbiphenyl, 4,4'-divinylbiphenyl, 2,2-bis(4-vinylphenyl)propane, bis(4-vinylphenyl)ether, vinylnaphthalene, and divinylnaphthalene.

[0028] The styrene derivative preferably contains at least one selected from the group consisting of divinylbenzene, α-methylstyrene, and α-methylstyrene dimer. α-Methylstyrene and α-methylstyrene dimer can function as chain transfer agents. When divinylbenzene is contained, the softening point of the cured product tends to be higher.

[0029] The styrene compound preferably contains styrene, more preferably contains both styrene and a styrene derivative, and further preferably contains styrene, α-methylstyrene, and α-methylstyrene dimer.

[0030] In the curable composition, the ratio M1 / M2 of the mass M1 of the fluorene group-containing compound to the mass M2 of the styrene compound is preferably 0.10 or more, more preferably 0.25 or more, and even more preferably 0.50 or more, from the viewpoint of increasing the refractive index of the cured body. The ratio M1 / M2 is preferably 1.0 or less, more preferably 0.90 or less, and even more preferably 0.80 or less, from the viewpoint of decreasing the specific gravity of the cured body. The ratio M1 / M2 may be 1.1 or less.

[0031] In the curable composition, the ratio M1 / M3 of the mass M1 of the fluorene group compound to the mass M3 of styrene is preferably 0.20 or more, more preferably 0.50 or more, and even more preferably 0.80 or more, from the viewpoint of increasing the refractive index of the cured body. The ratio M1 / M3 is preferably 1.50 or less, more preferably 1.20 or less, from the viewpoint of decreasing the specific gravity of the cured body. The ratio M1 / M3 may be 1.40 or less.

[0032] In the curable composition, the proportion of the styrene compound is preferably 10% by mass or more, more preferably 20% by mass or more, and even more preferably 30% by mass or more, from the viewpoint of reducing the specific gravity of the cured body. In terms of increasing the refractive index of the cured body, the proportion of the styrene compound is preferably 70% by mass or less, more preferably 60% by mass or less, and even more preferably 50% by mass or less. This proportion may be 80% by mass or less, or may be 55% by mass or less.

[0033] In the curable composition, the proportion of styrene is preferably 20% by mass or more and 80% by mass or less, more preferably 30% by mass or more and 60% by mass or less, and may be 35% by mass or more and 50% by mass or less.

[0034] In the curable composition, the proportion of the styrene derivative is preferably 1% by mass or more and 20% by mass or less, and more preferably 5% by mass or more and 15% by mass or less.

[0035] In the curable composition, the proportion of α-methylstyrene dimer is preferably 0.1% by mass or more and 10% by mass or less, and more preferably 1% by mass or more and 5% by mass or less.

[0036] In the curable composition, the proportion of α-methylstyrene is preferably 1% by mass or more and 20% by mass or less, and more preferably 5% by mass or more and 15% by mass or less.

[0037] The curable composition may contain divinylbenzene to increase the softening point. In this case, the proportion of divinylbenzene is preferably 1% by mass or more and 20% by mass or less, more preferably 3% by mass or more and 10% by mass or less. This proportion may be 1% by mass or more and 5% by mass or less.

[0038] When the styrene compound contains a mixture of styrene and its derivatives, the proportion of styrene in the mixture is preferably 50% by mass or more and 95% by mass or less, more preferably 80% by mass or more and 90% by mass or less, and may be 65% by mass or more.

[0039] The proportion of the styrene compound, styrene, styrene derivative, etc. in the curable composition can be calculated, for example, by subjecting the curable composition to silica gel chromatography, in the same manner as for the sulfur-containing compound.

[0040] (Hydroxyl Group-Containing (Meth)acrylate) The hydroxyl group-containing (meth)acrylate is a compound having one or more hydroxyl groups and one or more (meth)acryloyl groups. The hydroxyl group-containing (meth)acrylate preferably has 1 to 6 hydroxyl groups, more preferably 1 to 4 hydroxyl groups, and even more preferably 2 hydroxyl groups. The hydroxyl group-containing (meth)acrylate preferably has 1 to 6 (meth)acryloyl groups, more preferably 1 to 4 hydroxyl groups, and even more preferably 2 hydroxyl groups.

[0041] Examples of the compound containing one hydroxyl group and one (meth)acryloyl group include compounds represented by the following formula (2).

[0042]

[0043] In the formula, g is an average value of 1 to 20. g is preferably 1.

[0044] A is a linear or branched alkylene group having 2 to 5 carbon atoms, and is preferably an ethylene group.

[0045] R 11 is a hydrogen atom or a methyl group. 11is preferably a methyl group. 12 is a hydrogen atom.

[0046] Specific examples of the compound represented by formula (2) include 2-(hydroxyethyl)(meth)acrylate, hydroxypropyl(meth)acrylate, 4-(hydroxybutyl)(meth)acrylate, and the like.

[0047] The hydroxyl group-containing (meth)acrylate preferably includes an epoxy di(meth)acrylate represented by the following formula (II).

[0048]

[0049] In formula (II), R 35 , and R 36 are each independently a hydrogen atom or a methyl group. 35 , and R 36 is preferably a hydrogen atom from the viewpoint of reducing the specific gravity of the cured body. 35 , and R 36 is preferably a methyl group from the viewpoint of increasing the softening point of the cured product.

[0050] A and B each independently represent a linear or branched alkylene group having 1 to 4 carbon atoms which may be substituted with a hydroxy group.

[0051] E is any group represented by the following formula:

[0052]

[0053] E is -C(CH 3 ) 2 It is preferable that −.

[0054] p+q is 0 or an integer of 1 to 20. p+q is preferably 0.

[0055] Specifically, the structure represented by formula (II) is preferably a structure represented by the following formula:

[0056]

[0057] Other hydroxyl group-containing (meth)acrylates include glycerin di(meth)acrylate and 2-hydroxy-3-acryloyloxypropyl methacrylate.

[0058] The proportion of the hydroxyl group-containing (meth)acrylate in the curable composition is preferably 1% by mass or more, more preferably 4% by mass or more, and even more preferably 10% by mass or more, from the viewpoint of improving the adhesiveness of the cured body. From the viewpoint of increasing the refractive index of the cured body, it is preferably 50% by mass or less, preferably 30% by mass or less, and more preferably 25% by mass or less. This proportion may be 8% by mass or more.

[0059] The ratio M7 / M1 of the mass M7 of the hydroxyl group-containing (meth)acrylate to the mass M1 of the fluorene group-containing compound is, for example, 0.1 or more and 3 or less, preferably 0.2 or more and 1 or less.

[0060] The ratio M7 / M2 of the mass M7 of the hydroxyl group-containing (meth)acrylate to the mass M2 of the styrene compound is, for example, 0.010 or more and 3.0 or less, preferably 0.10 or more and 1.0 or less, and more preferably 0.2 or more and 0.7 or less. This ratio M7 / M2 may be 0.15 or more and 0.70 or less.

[0061] In the total amount of the styrene compound, the fluorene group-containing compound, and the hydroxyl group-containing (meth)acrylate, it is preferred that the proportion of the styrene compound is 30% by mass or more and 60% by mass or less, the proportion of the fluorene group-containing compound is 10% by mass or more and 50% by mass or less, and the proportion of the hydroxyl group-containing (meth)acrylate is 1% by mass or more and 30% by mass or less.

[0062] (Other (meth)acrylates) The curable composition according to this embodiment may contain a (meth)acrylate in addition to the above-described components. The (meth)acrylate is a monomer having at least one of an acryloyl group and a methacryloyl group. The (meth)acrylate includes a monofunctional (meth)acrylate having one (meth)acryloyl group, a di(meth)acrylate having two (meth)acryloyl groups, and a polyfunctional (meth)acrylate having three or more (meth)acryloyl groups. From the viewpoints of increasing static pressure resistance and improving the flexibility of the cured body, it is preferable that the (meth)acrylate contains a di(meth)acrylate.

[0063] Specific examples of the (meth)acrylate include ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, ethylene glycol bisglycidyl (meth)acrylate, bisphenol A di(meth)acrylate, hydroxyethyl methacrylate, 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, and 2,2-bis(3,5-dibromo-4-(meth)acryloyloxyethoxyphenyl)propane.

[0064] In the curable composition, the ratio M1 / M4 of the mass M1 of the fluorene group-containing compound to the mass M4 of the other (meth)acrylate is preferably 0.1 or more and 4 or less, more preferably 0.5 or more and 3 or less, and even more preferably 0.5 or more and 2 or less. This ratio M1 / M4 may be 1.0 or more and 10 or less, or may be 20.0 or more and 9.0 or less.

[0065] In the curable composition, the ratio M3 / M4 of the mass M3 of styrene to the mass M4 of the other (meth)acrylate is preferably 1.0 or more and 20 or less, and more preferably 2 or more and 10 or less. This ratio M3 / M4 may be 1.6 or more.

[0066] In the curable composition, the proportion of the other (meth)acrylate is preferably 5% by mass or more, more preferably 9% by mass or more, and even more preferably 14% by mass or more, from the viewpoint of increasing the static pressure resistance of the cured body, and is preferably 30% by mass or less, more preferably 20% by mass or less, from the viewpoint of decreasing the specific gravity of the cured body.

[0067] The (meth)acrylate preferably contains bisphenol A di(meth)acrylate. When the curable composition contains bisphenol A di(meth)acrylate, a tough cured product with excellent resistance to static pressure can be obtained.

[0068] The bisphenol A di(meth)acrylate contains at least one compound selected from the group consisting of alkoxylated bisphenol A acrylate and alkoxylated bisphenol A methacrylate. The alkoxylated bisphenol A acrylate contains at least one compound selected from the group consisting of ethoxylated bisphenol A acrylate and propoxylated bisphenol A acrylate. The alkoxylated bisphenol A methacrylate contains at least one compound selected from the group consisting of ethoxylated bisphenol A methacrylate and propoxylated bisphenol A methacrylate.

[0069] The bisphenol A di(meth)acrylate preferably contains a compound represented by the following formula (1).

[0070]

[0071] In the above formula (1), R 4 and R 5 are each a hydrogen atom or a methyl group. a is an integer of 1 or more and 10 or less. b is an integer of 1 or more and 10 or less. a+b is an integer of 2 or more and 20 or less, and a+b is preferably an integer of 2 or more and 5 or less. a+b may be 10 or less.

[0072] In the curable composition, the ratio M1 / M6 of the mass M1 of the fluorene group-containing compound to the mass M6 of bisphenol A di(meth)acrylate is preferably 0.1 or more and 4 or less, more preferably 0.5 or more and 3 or less, and even more preferably 0.5 or more and 2 or less. This ratio M1 / M6 may be 1.0 or more and 10 or less, or may be 2.0 or more and 9.0 or less.

[0073] In the curable composition, the ratio M3 / M6 of the mass M3 of styrene to the mass M6 of bisphenol A di(meth)acrylate is preferably 1.0 or more and 20 or less, and more preferably 2 or more and 10 or less. This ratio M3 / M6 may be 1.6 or more.

[0074] In the curable composition, the proportion of bisphenol A di(meth)acrylate is preferably 5% by mass or more, more preferably 9% by mass or more, and even more preferably 14% by mass or more, from the viewpoint of increasing the static pressure resistance of the cured body, and is preferably 30% by mass or less, more preferably 20% by mass or less, from the viewpoint of decreasing the specific gravity of the cured body.

[0075] In the total amount of the styrene compound, the fluorene group-containing compound, the hydroxyl group-containing (meth)acrylate, and the bisphenol A di(meth)acrylate, it is preferred that the proportion of the styrene compound is 30% by mass or more and 45% by mass or less, the proportion of the fluorene group-containing compound is 10% by mass or more and 45% by mass or less, the proportion of the hydroxyl group-containing (meth)acrylate is 1% by mass or more and 15% by mass or less, and the proportion of the bisphenol A di(meth)acrylate is 1% by mass or more and 20% by mass or less.

[0076] The proportion of other (meth)acrylates in the curable composition can be calculated, for example, by silica gel chromatography of the curable composition, in the same manner as for the sulfur-containing compound. The total number of polymerizable functional groups FN of the curable composition is preferably 4.0 mmol / g or more and 10.0 mmol / g or less. When the total number of polymerizable functional groups FN is within this range, a cured product having sufficient hardness can be obtained. The total number of polymerizable functional groups FN is more preferably 5.0 mmol / g or more and 9.0 mmol / g or less, and even more preferably 5.5 mmol / g or more and 7.0 mmol / g or less. From the viewpoint of compatibility of the curable composition, the number of (meth)acryloyl groups MN of the curable composition is preferably 5.0 mmol / g or less, more preferably 2.0 mmol / g or less, and even more preferably 1.5 mmol / g or less. The number of (meth)acryloyl groups MN in the curable composition is preferably 0.1 mmol / g or more, more preferably 0.5 mmol / g or more, and even more preferably 1.0 mmol / g or more, from the viewpoint of increasing the softening point of the cured product. In the curable composition, the proportion of the number of (meth)acryloyl groups MN to the total number of polymerizable functional groups FN, i.e., the (meth)acryloyl ratio (MN / FN), is preferably 30% or less, more preferably 25% or less, and even more preferably 20% or less, from the viewpoint of compatibility of the curable composition. In the curable composition, the (meth)acryloyl ratio (MN / FN) is preferably 2% or more, more preferably 10% or more, and even more preferably 15% or more, from the viewpoint of increasing the softening point of the curable composition. The total number of polymerizable functional groups FN and the number of (meth)acryloyl groups MN in the curable composition can be calculated from the molar amount of each functional group in each polymerizable compound.

[0077] (Polymerization initiator) The polymerization initiator is mainly used for curing the curable composition containing at least one of a cationically polymerizable monomer and a radically polymerizable monomer. As the polymerization initiator, a thermal polymerization initiator or a photopolymerization initiator may be used.

[0078] As the radical thermal polymerization initiator, at least one selected from the group consisting of dialkyl peroxides, peroxy esters, percarbonates, and azo compounds can be used.

[0079] The radical photopolymerization initiator may be at least one selected from the group consisting of benzophenone, acetophenone-based compounds, α-dicarbonyl-based compounds, and acylphosphine oxide-based compounds. The acylphosphine oxide-based compounds include 2,6-dimethylbenzoyldiphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoyldiphenylphosphine acid methyl ester, 2,6-dichlorobenzoyldiphenylphosphine oxide, and 2,6-dimethoxybenzoyldiphenylphosphine oxide.

[0080] The amount of the polymerization initiator in the curable composition is, for example, 0.01% by mass or more and 5% by mass or less, and preferably 0.1% by mass or more and 3% by mass or less.

[0081] The polymerizable composition preferably contains a low-temperature polymerization initiator having a one-minute half-life temperature of less than 100°C. Use of a low-temperature polymerization initiator can suppress clouding of the cured product. Specifically, the cured product is produced, for example, by injecting the curable composition into a mold composed of two glass plates and polymerizing it. The mold may be produced by adhering the two glass plates together with adhesive tape or the like. The liquid styrene compound contained in the curable composition tends to be highly compatible with various organic compounds. When the adhesive tape comes into contact with the curable composition, the liquid styrene compound dissolves the organic compound contained in the adhesive tape, etc., and impurities may be introduced into the curable composition. These impurities may cause clouding of the cured product. Use of a polymerization initiator having a one-minute half-life temperature of less than 100°C can initiate polymerization of the curable composition early at a relatively low temperature. This allows the liquid styrene compound to cure early, thereby suppressing the introduction of impurities into the curable composition.

[0082] The one-minute half-life temperature of the low-temperature polymerization initiator is preferably 80°C or higher and lower than 100°C, and more preferably 90°C or higher and 95°C or lower.

[0083] Examples of low-temperature polymerization initiators that can be used include 1,1,3,3-tetramethylbutyl peroxyneodecanoate (Perocta (registered trademark) ND), cumyl peroxyneodecanoate (Percomyl (registered trademark) ND), diisopropyl peroxydicarbonate (Perloyl (registered trademark) IPP), di(2-ethylhexyl)peroxydicarbonate (Perloyl (registered trademark) OPP), diisobutyryl peroxide (Perloyl (registered trademark) IB), di-n-propyl peroxydicarbonate (Perloyl (registered trademark) NPP), di-sec-butyl peroxydicarbonate (Perloyl (registered trademark) SBP), and di(4-t-butylcyclohexyl)peroxydicarbonate (Perloyl (registered trademark) TCP).

[0084] The amount of the low-temperature polymerization initiator in the curable composition is, for example, 0.01% by mass or more and 5% by mass or less, preferably 1.0% by mass or more and 3.0% by mass or less. This proportion may be 0.1% by mass or more.

[0085] The ratio M10 / M2 of the mass M10 of the low-temperature polymerization initiator to the mass M2 of the styrene compound is preferably 0.001 or more and 0.1 or less, more preferably 0.010 or more and 0.050 or less, and even more preferably 0.020 or more and 0.040 or less. This ratio M10 / M2 may be 0.005 or more.

[0086] The polymerizable composition preferably contains a high-temperature polymerization initiator having a one-minute half-life temperature of 100°C or higher. By containing the high-temperature polymerization initiator, the polymerizability can be improved and the amount of residual monomer can be reduced. It is more preferable that the polymerizable composition contains a combination of a high-temperature polymerization initiator and a low-temperature polymerization initiator.

[0087] The one-minute half-life temperature of the high-temperature polymerization initiator is preferably 100°C or higher and 140°C or lower, and more preferably 101°C or higher and 130°C or lower.

[0088] Examples of high-temperature polymerization initiators include 1,1,3,3-tetramethylbutylperoxy-2-ethylhexanoate (Perocta (registered trademark) O), t-butylperoxyneodecanoate (Perbutyl (registered trademark) ND), t-butylperoxypivalate (Perbutyl (registered trademark) PV), t-butylperoxy-2-ethylhexanoate (Perbutyl (registered trademark) O), t-hexylperoxyneodecanoate (Perhexyl (registered trademark) ND), t-hexylperoxypivalate (Perhexyl (registered trademark) PV), Examples of compounds that can be used include di(3,5,5-trimethylhexanoyl)peroxide (Perloyl (registered trademark) 355), dilauroyl peroxide (Perloyl (registered trademark) L), disuccinic acid peroxide (Perloyl (registered trademark) SA), 2,5-dimethyl-2,5-di(2-ethylhexanoylperoxy)hexane (Perhexa (registered trademark) 25O), t-hexylperoxy-2-ethylhexanoate (Perhexyl (registered trademark) O), and dibenzoyl peroxide (Nyper (registered trademark) BW).

[0089] The amount of the high-temperature polymerization initiator in the curable composition is, for example, 0.01% by mass or more and 5% by mass or less, preferably 0.1% by mass or more and 2% by mass or less, more preferably 0.2% by mass or more and 1% by mass or less, and this proportion may be 3% by mass or less.

[0090] The ratio M10 / M11 of the mass M11 of the high-temperature polymerization initiator to the mass M10 of the low-temperature polymerization initiator is preferably 0.1 or more and 10 or less, more preferably 1 or more and 8 or less, and even more preferably 1.5 or more and 5 or less. This ratio M10 / M11 may be 0.2 or more, or may be 0.4 or more.

[0091] (Ultraviolet Absorber) The curable composition preferably contains an ultraviolet absorber. The ultraviolet absorber has a peak in the wavelength region of 400 nm or less in its absorption spectrum. By including an ultraviolet absorber, discoloration of the cured body can be suppressed. That is, sulfur-containing compounds and styrene compounds may be decomposed by ultraviolet light. When these compounds are decomposed, radicals may be generated. The radicals may promote oxidative deterioration of the cured body, for example, causing a colorless, transparent cured body to discolor to yellow.

[0092] The ultraviolet absorber preferably has a peak in its absorption spectrum in at least one of the wavelength ranges of 280 nm to less than 320 nm and 320 nm to 360 nm. The ultraviolet absorber more preferably has peaks in both the wavelength ranges of 280 nm to less than 320 nm and 320 nm to 360 nm. The ultraviolet absorber more preferably has a peak in at least one of the wavelength ranges of 290 nm to less than 310 nm and 330 nm to 350 nm, and even more preferably has peaks in both of these wavelength ranges.

[0093] The absorption spectrum of the ultraviolet absorber has wavelength on the horizontal axis and absorbance on the vertical axis. The absorption spectrum can be measured using a spectrophotometer. As a measurement sample, for example, a chloroform solution containing a 10 μM ultraviolet absorber dissolved therein and adjusted to a temperature of 23° C. is used.

[0094] An organic compound can be used as the ultraviolet absorber. For example, at least one selected from the group consisting of benzotriazole derivatives, benzophenone derivatives, ethylhexyl methoxycinnamate, and triazine derivatives is used as the ultraviolet absorber. The ultraviolet absorber preferably contains at least one selected from the group consisting of benzotriazole derivatives, benzophenone derivatives, cyanoacrylate derivatives, and ethylhexyl methoxycinnamate, more preferably contains at least one selected from the group consisting of benzotriazole derivatives and ethylhexyl methoxycinnamate, and even more preferably contains a benzotriazole derivative.

[0095] The benzotriazole derivative preferably includes a compound represented by the following formula (3).

[0096]

[0097] In formula (3), R 21 is an alkyl group having 1 to 10 carbon atoms, or an oxyalkyl group having 1 to 10 carbon atoms. 21 is preferably a methyl group or an oxyoctyl group.

[0098] Examples of benzophenone derivatives that can be used include octabenzone products such as Adekastab 1413 from ADEKA Corporation and SEESORB 107 and SEESORB L58 from Shipro Chemical Co., Ltd. Examples of cyanoacrylate derivatives that can be used include Uvinul (registered trademark) 3039 from BASF Corporation. Examples of ethylhexyl methoxycinnamate that can be used include Uvinul (registered trademark) MC-80 from BASF Corporation. Examples of benzotriazole derivatives that can be used include Adekastab LA-32 and LA-36 from ADEKA Corporation and SEESORB 707 from Shipro Chemical Co., Ltd. Examples of triazine derivatives that can be used include Adekastab LA-46 from ADEKA Corporation.

[0099] The ultraviolet absorber may be used alone or in combination of two or more.For example, an ultraviolet absorber having a maximum absorption wavelength in the wavelength region of 280 nm or more and less than 320 nm may be used in combination with an ultraviolet absorber having a maximum absorption wavelength in the wavelength region of 320 nm or more and 360 nm or less.Also, an ultraviolet absorber having peaks in both the wavelength region of 280 nm or more and less than 320 nm and the wavelength region of 320 nm or more and 360 nm or less may be used in combination with an ultraviolet absorber having peaks in the wavelength region of 300 nm or more and 320 nm or less.

[0100] The content of the ultraviolet absorber in the curable composition is, for example, 0.1 mass % or more and 10 mass % or less, preferably 0.5 mass % or more and 5 mass % or less, and more preferably 0.8 mass % or more and 3 mass % or less.

[0101] (Photochromic Compound) The curable composition may contain a photochromic compound. A photochromic compound is a compound that can reversibly generate two or more isomers having different light absorption spectra by the action of light. A photochromic compound becomes an isomer that exhibits a colorless, bleached state when exposed to ultraviolet light, i.e., a colorless form, and becomes an isomer that exhibits a colored state when exposed to ultraviolet light, i.e., a colored form. A cured product of a curable composition containing a photochromic compound has a photochromic function that changes color depending on the amount of ultraviolet light exposure, i.e., photochromic properties. Such cured products are used, for example, in photochromic lenses, jewelry, etc.

[0102] As the photochromic compound, for example, at least one selected from the group consisting of chromene compounds, fulgide compounds, and spirooxazine compounds is used. As the photochromic compound, a chromene compound is preferably used. Chromene compounds include compounds having a 1-benzopyran skeleton, spiropyran compounds containing a spiropyran skeleton, and naphthopyran compounds having a naphthopyran skeleton. Naphthopyran compounds include indenonaphthopyran compounds having an indenonaphthopyran skeleton. Chromene compounds preferably include indenonaphthopyran compounds having an indeno[2,1-f]naphtho[1,2-b]pyran skeleton. Cured products containing chromene compounds having an indeno[2,1-f]naphtho[1,2-b]pyran skeleton tend to have excellent durability.

[0103] (Other Additives) The curable composition may contain other additives, such as at least one selected from the group consisting of a release agent, a blue light absorber, a high-energy visible light absorber, an infrared absorber, an antioxidant, a coloring inhibitor, an antistatic agent, a fluorescent dye, a dye, a pigment, a fragrance, a solvent, a leveling agent, and a polymerization modifier.

[0104] As the blue light absorber, a compound having an absorption peak in the wavelength region of more than 400 nm and not more than 450 nm in its absorption spectrum can be used. Such a compound is, for example, at least one selected from the group consisting of perylene compounds, porphyrin compounds, carotenoid compounds, and cyanine compounds. As the blue light absorber, a porphyrin compound is preferably used, and a tetraazaporphyrin compound is more preferably used.

[0105] The high-energy visible light absorber is a blue light absorber having an absorption peak in the wavelength region of 400 nm or more and 420 nm or less. As the high-energy visible light absorber, the same one as the blue light absorber can be used.

[0106] The dye preferably contains a compound having an absorption peak in the wavelength region of 540 nm to 650 nm in its absorption spectrum, and more preferably a compound having an absorption peak in the wavelength region of 550 nm to 600 nm. The inclusion of such a compound enhances the antiglare properties of the cured product. Examples of such compounds include nitro-based compounds, azo-based compounds, anthraquinone-based compounds, threne-based compounds, porphyrin-based compounds, and rare earth metal compounds. It is preferable to use at least one compound selected from the group consisting of tetraazaporphyrin compounds and neodymium compounds.

[0107] [Cured Product] A cured product can be obtained by curing the curable composition according to the embodiment.

[0108] The cured product of the curable composition according to the embodiment can achieve a high refractive index of 1.55 or more, 1.59 or more, or 1.60 or more. The refractive index of the cured product can be measured using, for example, a commercially available refractometer. Specifically, it can be measured using an Abbe refractometer NAR-3T manufactured by ATAGO Corporation.

[0109] The cured product of the curable composition according to the embodiment can have a low specific gravity of 1.20 or less, 1.15 or less, or 1.13 or less. The specific gravity of the cured product can be measured using, for example, a commercially available hydrometer. Specifically, it can be measured using an automatic hydrometer DSG-1 manufactured by Toyo Seiki Seisakusho, Ltd.

[0110] The softening point of the cured product of the curable composition according to the embodiment is preferably 100°C or higher. If the softening point is high, the cured product is less likely to deform. The softening point of the cured product is preferably 105°C or higher, and more preferably 110°C or higher. There is no particular upper limit to the softening point of the cured product, but in one example, it is 130°C or lower. The softening point of the cured product can be measured, for example, by thermomechanical analysis.

[0111] The shape of the cured product is not particularly limited. The cured product can be used as an optical article. Examples of optical articles include plastic lenses such as semi-finished lenses and finished lenses, windows for automobiles and buildings, information recording devices, decorative articles, etc. The cured product according to the embodiment is suitably used as a lens substrate for a plastic lens.

[0112] A cured product of the curable composition can be obtained, for example, by a cast polymerization method. Specifically, the curable composition is filled into a mold and thermally polymerized. Heating conditions include, for example, raising the temperature from the initial temperature to the curing temperature over a period of 10 to 60 hours. The initial temperature is, for example, from room temperature to 50°C. The curing temperature is, for example, from 80°C to 120°C.

[0113] [Lens] The lens according to the embodiment includes an optical article including the cured body according to the embodiment. The lens according to the embodiment may be a semi-finished lens or a finished lens.

[0114] The lens according to the embodiment may include a lens substrate containing the cured product according to the embodiment and a hard coat layer provided on at least one major surface of the lens substrate. The hard coat layer may be provided on both sides of the lens substrate. An anti-reflection film may be present on the surface of the hard coat layer. At least one of an adhesive layer, a photochromic layer, and a polarizing layer may be present between the lens substrate and the hard coat layer.

[0115] A lens according to an embodiment may include, for example, a lens substrate, an adhesive layer provided on the surface of the lens substrate, and a hard coat layer provided on the adhesive layer.A lens according to an embodiment may include, for example, a laminate of a lens substrate, an adhesive layer provided on the surface of the lens substrate, a photochromic layer provided on the adhesive layer, a hard coat layer provided on the photochromic layer, and an anti-reflection film provided on the hard coat layer.

[0116] A lens according to an embodiment may include a lens substrate containing a cured product and a photochromic layer provided on at least one major surface of the lens substrate.

[0117] The hard coat layer contains, for example, a silicon-containing compound such as an organic silane or an inorganic silane, and an inorganic oxide. Examples of the inorganic oxide include titanium oxide (TiO 2 ), zirconium oxide (ZrO 2 ), cerium oxide (CeO 2Materials with high refractive indexes, such as titanium oxide and cerium oxide, are used. These inorganic oxides have ultraviolet absorbing properties. Therefore, lenses provided with a hard coat layer containing these inorganic oxides are less likely to discolor. In terms of high ultraviolet absorbing properties, it is preferable that the hard coat layer contains at least one inorganic oxide selected from the group consisting of titanium oxide and cerium oxide.

[0118] An anti-reflection film is a film that prevents light reflection by interference. The anti-reflection film has a multi-layer structure in which a relatively high refractive index film and a low refractive index film are stacked. The low refractive index film is, for example, a silicon dioxide (SiO 2 The high refractive index film is made of a material having a higher refractive index than the low refractive index layer. Examples of such materials include zirconium oxide (ZrO 2 ), tin oxide (SnO 2 ), niobium oxide (Nb 2 O 5 ), tantalum oxide (Ta 2 O 5 ), titanium oxide (TiO 2 ), yttrium oxide (Y 2 O 3 ), aluminum oxide (Al 2 O 3 ), a mixture thereof (for example, indium tin oxide (ITO)), or the like is used.

[0119] The photochromic layer contains, for example, the above-described photochromic compound and a resin. The resin may include at least one resin selected from the group consisting of polyester resin, polyamide resin, allyl resin, acrylic resin, methacrylic resin, polyurethane resin, polyurethane urea resin, polythiourethane resin, polythiourethane urea resin, polythioepoxy resin, and polycarbonate resin.

[0120] The adhesive layer may contain the resins listed as examples of resins that may be contained in the photochromic layer. The adhesive layer preferably uses a urethane resin. An adhesive layer containing a urethane resin tends to have high adhesion to the cured product according to the embodiment. The provision of the adhesive layer tends to increase the impact resistance of the lens. The adhesive layer is obtained, for example, by applying a primer composition to the lens substrate and drying it. The primer composition preferably uses a dispersion of a moisture-curing urethane resin or a urethane prepolymer thereof.

[0121] The polarizing layer can be formed, for example, by applying a dichroic dye to the surface of the lens substrate. Alternatively, a polarizing film may be used as the polarizing layer. The polarizing film may be a film obtained by dyeing a stretched or unstretched polyvinyl alcohol (PVA) film with a dichroic dye.

[0122] The lens according to the embodiment may be a laminate of first and second lens substrates containing the cured product according to the embodiment and a binder sheet positioned between the first and second lens substrates. One main surface of the binder sheet is covered by the first lens substrate, and the other main surface is covered by the second lens substrate. The side surfaces of the binder sheet may also be covered by the lens substrate. The binder sheet includes, for example, first and second optical sheets and an adhesive layer positioned between the first and second optical sheets to bond them together. The first and second optical sheets contain at least one resin selected from the group consisting of polyvinyl alcohol resin, polyethylene terephthalate resin, polycarbonate resin, polyamide resin, polyester resin, cellulose resin, (meth)acrylic resin, polyurethane resin, polyurethane urea resin, polyimide resin, epoxy resin, and polyolefin resin. When a polyvinyl alcohol resin film is used as the optical sheet, it may have a polarization function. The adhesive layer may contain a functional dye such as a photochromic compound.

[0123] Fig. 1 is a cross-sectional view schematically illustrating an example of a lens according to an embodiment. The lens 10 shown in Fig. 1 includes a lens substrate 11, a hard coat layer 12 provided on the convex main surface of the lens substrate 1, and an adhesive layer 1 located between the lens substrate 11 and the hard coat layer 12.

[0124] Fig. 2 is a perspective view schematically illustrating an example of eyeglasses according to an embodiment. The eyeglasses 100 shown in Fig. 2 include a lens 101 and a frame 102 that supports the lens 101. The lens 101 includes an optical article according to an embodiment.

[0125] The present invention will be described in more detail by the following examples, which are merely illustrative of the present invention and are not intended to limit the scope and spirit of the present invention.

[0126] Example 1 Preparation of Curable Composition A curable composition was prepared by mixing 70 parts by mass of styrene, 20 parts by mass of FA1, 2 parts by mass of α-methylstyrene dimer, 8 parts by mass of α-methylstyrene, 2 parts by mass of UVA1, 2 parts by mass of PI1, and 1 part by mass of PI3.

[0127] (Preparation of Cured Product) First, a mold was prepared by fixing two glass plates with a 2 mm gap between them with adhesive tape (Jantape, JT8865C3). Next, the curable composition was thoroughly stirred and mixed, degassed under vacuum, and then poured into the mold and polymerized by thermal polymerization. The polymerization was carried out over 21 hours while gradually increasing the temperature from 35°C to 90°C using an air oven. After polymerization was completed, the cured product was removed from the mold. The shape of the cured product was a flat plate with a diameter of 80 mm and a thickness of 2 mm.

[0128] (Preparation of Laminate) The surface of the obtained cured body was chemically treated with a 20% by mass sodium hydroxide solution. A urethane resin primer (TS-56-PH3 manufactured by Tokuyama Corp.) was applied to the main surface of the chemically treated cured body by dip coating to form a coating film. The primer layer had a thickness of 1 μm. After this coating film was thoroughly dried, a thermosetting composition HC1 (TS-56-KAH manufactured by Tokuyama Corp.) was applied by dip coating to form a coating film. The thermosetting composition HC1 contains zirconia, ceria, a silane coupling agent, and an organic solvent. After this coating film was thoroughly dried, the dried coating film was thermally cured. During thermal curing, the film was heated at a temperature of 110°C for 3 hours. In this way, a laminate was obtained in which a hard coat layer was laminated on the main surface of the cured body. The hard coat layer had a thickness of 2 μm.

[0129] Examples 2 to 20, Examples 23 to 26 Cured products were obtained in the same manner as in Example 1, except that the formulation of the curable composition was changed as shown in Table 1 or Table 2 below. The details of the abbreviations in Tables 1 and 2 are as follows: MSD: α-methylstyrene dimer. MS: α-methylstyrene. DVB: divinylbenzene. FA1: OGSOL EA-0200 (R=H, m+n=2) (manufactured by Osaka Gas Chemicals Co., Ltd.). FA2: KOMERATE D064 (R=H, m+n=6) (manufactured by KPX Co., Ltd.). FM1: R=CH 3 , m+n=2.

[0130]

[0131] (Synthesis Example of FM1) 50 g of bisphenoxyethanolfluorene (BPEF, manufactured by Osaka Gas Chemicals Co., Ltd.) and 40 mL of dichloromethane were added to a 100 mL flask and cooled to 10°C. Then, 26 g (2.2 eq.) of methacrylic acid chloride and 27 g (2.4 eq.) of triethylamine were added dropwise and stirred at room temperature for 5 hours. Thereafter, the reaction solution was washed three times with 3% hydrochloric acid and three times with water, and then washed three times with a 10% aqueous sodium hydroxide solution and three times with water. The organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain FM1 (R = CH 3 ) was obtained (yield: 75%).

[0132] The obtained compound was dissolved in deuterated chloroform, and then 1 Measurements were performed using a H-nuclear magnetic resonance spectrometer (JNM-ECA400II, 400 MHz, reference material: TMS, manufactured by JEOL Ltd.). The proton nuclear magnetic resonance spectrum of FM1 showed the following peaks: δ 1.92 (m, 6H), 4.15 (t, 4H), 4.45 (t, 4H), 5.55 (m, 2H), 6.10 (m, 2H), 6.76 (d, 4H), 7.11 (d, 4H), 7.25 (m, 2H), 7.32-7.37 (m, 4H), 7.75 (m, 2H).

[0133] 3000A: Epoxy ester 3000A (R=H in the following formula) (manufactured by Kyoeisha Chemical Co., Ltd.) 3000MK: Epoxy ester 3000MK (R=Me in the following formula) (manufactured by Kyoeisha Chemical Co., Ltd.).

[0134]

[0135] HEMA: Hydroxyethyl methacrylate represented by the following formula.

[0136]

[0137] BPE100: Bisphenol A dimethacrylate represented by the formula below. The average value of m+n is 2.6. BPE200: Bisphenol A dimethacrylate represented by the formula below. The average value of m+n is 4. BPE500: Bisphenol A dimethacrylate represented by the formula below. The average value of m+n is 10.

[0138]

[0139] ABE300: Bisphenol A diacrylate represented by the following formula, where the average value of a+b is 3.

[0140]

[0141] UVA1: An ultraviolet absorber represented by the following formula:

[0142]

[0143] UVA2: An ultraviolet absorber represented by the following formula:

[0144]

[0145] PI1: Polymerization initiator Perocta (registered trademark) ND (1-minute half-life temperature: 92.4°C) PI2: Polymerization initiator Perbutyl (registered trademark) ND (1-minute half-life temperature: 103.5°C) PI3: Polymerization initiator Perocta (registered trademark) O (1-minute half-life temperature: 124.3°C)

[0146] ((Meth)acryloyl Group Ratio in Each Curable Composition) The (meth)acryloyl group ratio in each curable composition was calculated using the following formula (a), and is shown in Tables 4 and 5. ((Meth)acryloyl Group Ratio) = [(Number of (meth)acryloyl Groups) / (Total Number of Polymerizable Functional Groups)] × 100 (a)

[0147] <Evaluation Test> (Softening Point) The softening point of the cured products of Examples 1 to 20 and 23 to 26 was measured using a thermomechanical analyzer TMA8311 manufactured by Rigaku Corporation (three-point bending method, heating rate: 10°C / min). The test results are shown in Table 3.

[0148] (Refractive Index) The refractive index of the cured products of Examples 1 to 20 and 23 to 26 was measured using an Abbe refractometer NAR-3T manufactured by ATAGO Co., Ltd. The test results are shown in Table 3.

[0149] (Specific Gravity) The specific gravity of the cured bodies of Examples 1 to 20 and 23 to 26 was measured using an automatic hydrometer DSG-1 manufactured by Toyo Seiki Seisakusho Co., Ltd. The test results are shown in Table 3.

[0150] (Opacity) The degree of turbidity of the cured products of Examples 1 to 20 and 23 to 26 was visually evaluated based on the following evaluation criteria. The test results are shown in Table 3.

[0151] (Evaluation Criteria) A: Transparency is observed when evaluated under fluorescent light, and no cloudiness is observed when evaluated with a concentrator. B: Transparency is observed when evaluated under fluorescent light, but cloudiness is observed when evaluated with a concentrator.

[0152] (Lightfastness Test) The HC1 laminates according to Examples 1 to 20 and 23 to 26 were subjected to a lightfastness test using a xenon weather meter X25 manufactured by Suga Test Instruments Co., Ltd.

[0153] Specifically, the sample was first irradiated with ultraviolet light using a xenon lamp for 144 hours. The test temperature was 50°C and the irradiance was 40 W / m 2 (300 nm to 400 nm). Next, the ultraviolet irradiation was stopped, and the yellowness of the sample was measured to obtain the yellowness YI of the sample after the light fastness test. The yellowness was measured using a touch panel color computer SM-T manufactured by Suga Test Instruments Co., Ltd. The test results are shown in Table 3.

[0154] (Adhesion Test) The HC1 laminates of Examples 1 to 20 and 23 to 26 were subjected to a cross-cut tape peel test in accordance with Japanese Industrial Standard JIS D0202:1988. Cellotape (registered trademark) manufactured by Nichiban Co., Ltd. was used as the cellophane adhesive tape. The adhesion was evaluated based on the number of squares that did not peel out of 100 squares, based on the following evaluation criteria. The test results are shown in Table 3.

[0155] (Evaluation criteria) A: 100 / 100. B: 99 / 100 to 95 / 100. C: Less than 95 / 100.

[0156]

[0157]

[0158]

[0159]

[0160]

[0161] Example 21 (Production of photochromic optical article) A cured product (without a hard coat layer) obtained according to the formulation shown in Table 2 and Example 18 was used as a lens substrate, and a photochromic cured product was laminated on the surface of the lens substrate to obtain a photochromic optical article.

[0162] (Preparation of Photochromic Curable Composition) Radical polymerizable monomers were mixed according to the formulation shown below to prepare a photochromic curable composition.

[0163] Polyethylene glycol dimethacrylate (average molecular weight 736): 42 parts by mass Polyethylene glycol dimethacrylate (average molecular weight 536): 12 parts by mass Trimethylolpropane trimethacrylate: 38 parts by mass γ-methacryloyloxypropyltrimethoxysilane: 2 parts by mass Glycidyl methacrylate: 1 part by mass

[0164] It should be noted that 0.27 mmol of a photochromic compound represented by the following formula (8) was added to 100 g of the curable composition.

[0165]

[0166] Furthermore, the following additives were blended in. The blending amounts shown below are blending ratios relative to 100 parts by mass of the curable composition.

[0167] Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide (photopolymerization initiator: Omnirad 819): 0.3 parts by mass Ethylenebis(oxyethylene)bis[3-(5-tert-butyl-4-hydroxy-m-tolyl)propionate] (stabilizer, Irganox 245): 1 part by mass Bis(1,2,2,6,6-pentamethyl-4-piperidyl)sebacate: 3 parts by mass Leveling agent (L7001) manufactured by Dow Corning Toray Co., Ltd.: 0.1 parts by mass.

[0168] (Production of Photochromic Laminate) First, a cured product (without a hard coat layer) having a center thickness of 2 mm obtained according to the formulation shown in Table 2 and Example 18 was prepared as a lens substrate. This lens substrate was previously subjected to alkaline etching using a 10% aqueous solution of sodium hydroxide at 50°C for 5 minutes, and then thoroughly washed with distilled water.

[0169] The surface of the lens substrate was coated with a moisture-curable primer (product name: TR-SC-P, manufactured by Tokuyama Corporation) using a spin coater (1H-DX2, manufactured by MIKASA) at a rotation speed of 70 rpm for 15 seconds, followed by 1000 rpm for 10 seconds. Approximately 2 g of the photochromic curable composition obtained above was then spin-coated at a rotation speed of 60 rpm for 40 seconds, followed by 600 rpm for 10 to 20 seconds, so that the coating layer had a thickness of 40 μm. The lens, whose surface was coated with the coating agent in this manner, was then spin-coated in a nitrogen gas atmosphere at an output of 200 mW / cm. 2 The coating was cured by irradiating the coating with light for 90 seconds using a metal halide lamp, and then further heating at 110°C for 1 hour to obtain a photochromic optical article in which a photochromic cured body was laminated on the surface of the lens substrate.

[0170] The photochromic optical articles thus obtained were evaluated by the following methods, and the evaluation results are shown in Table 6.

[0171] [Evaluation Method] <Photochromic Properties> The following values ​​were measured using a spectrophotometer (instant multichannel photodetector MCPD3000) manufactured by Otsuka Electronics Co., Ltd.

[0172] Maximum absorption wavelength (λmax): The maximum absorption wavelength after color development.

[0173] Color density: absorbance (A) at the maximum absorption wavelength after irradiating with light at 23°C for 300 seconds 300 ) and absorbance (A 0 ) is the difference.

[0174] Fading half-life [τ 1/2 (sec)]: the absorbance at the maximum absorption wavelength of the sample when the light irradiation is stopped after 300 seconds of light irradiation at 23°C. 300 -A 0} is the time required for the voltage to drop to half of the original voltage.

[0175] <Durability> Survival rate (%) = [(A 96 ) / (A 0) × 100]: The photochromic cured body was subjected to accelerated aging for 96 hours using a Xenon Weather Meter X25 manufactured by Suga Test Instruments Co., Ltd. The color density was evaluated before and after the accelerated aging test, and the color density (A 0 ) and the color density (A 96 ) ratio (A 96 / A 0 The higher the retention rate, the higher the color durability.

[0176] Example 22 A photochromic optical article was obtained in the same manner as in Example 21, except that a thiourethane-based plastic lens having a center thickness of 2 mm and a refractive index of 1.60 was used as the lens substrate.

[0177] The photochromic optical article thus obtained was evaluated in the same manner as in Example 21, and the evaluation results are shown in Table 6.

[0178]

[0179]

[0013] Preferred embodiments of the present invention are described below. [1] A curable composition comprising at least one styrene compound selected from the group consisting of styrene and styrene derivatives, a fluorene group-containing compound represented by the following formula (I), and a hydroxyl group-containing (meth)acrylate:

[0180]

[0181] In the formula (I), R 31 and R 32 are each independently an alkyl group, and R 33 and R 34 are each independently a hydrogen atom or a methyl group. X and Y are each independently a linear or branched alkylene group having 1 to 4 carbon atoms. Z 1 and Z 2 are each independently an aromatic carbocyclic ring having 5 to 10 carbon atoms or an alkylene group having 1 to 4 carbon atoms; Z 3 and Z 4are each independently an aromatic carbon ring having 5 to 8 carbon atoms or an alkyl group having 1 to 4 carbon atoms. m+n is an integer of 0 to 20, and o+q and p+r are each an integer of 0 to 4. [2] The curable composition according to [1], wherein the hydroxyl group-containing (meth)acrylate includes an epoxy di(meth)acrylate represented by the following formula (II):

[0182]

[0183] In the formula (II), R 35 , and R 36 are each independently a hydrogen atom or a methyl group, A and B are each independently a linear or branched alkylene group having 1 to 4 carbon atoms which may be substituted with a hydroxy group, and E is a group represented by the following formula:

[0184]

[0185] and p+q=0 to 20. [3] The curable composition according to [1] or [2], wherein the ratio M1 / M2 of the mass M1 of the fluorene group-containing compound to the mass M2 of the styrene compound is 0.10 or more and 1.0 or less. [4] The curable composition according to any of [1] to [3], wherein the proportion of the fluorene group-containing compound is 10% by mass or more and 50% by mass or less. [5] The curable composition according to any of [1] to [4], wherein the proportion of the hydroxyl group-containing (meth)acrylate is 1% by mass or more and 25% by mass or less. [6] The curable composition according to any of [1] to [5], wherein the proportion of the styrene compound is 10% by mass or more and 80% by mass or less. [7] The curable composition according to any of [1] to [6], further comprising an ultraviolet absorber. [8] The curable composition according to [7], wherein the ultraviolet absorber has a peak in at least one of a wavelength region of 280 nm or more and less than 320 nm and a wavelength region of 320 nm or more and 360 nm or less. [9] The curable composition according to any one of [1] to [8], further comprising a bisphenol (meth)acrylate compound represented by the following formula (III):

[0186]

[0187] In the formula (III), R 37 and R 38 are each independently a hydrogen atom or a methyl group, and m+n=1 to 20.

[10] The curable composition according to [9], wherein the proportion of the bisphenol (meth)acrylate compound is 0.1% by mass or more and 30% by mass or less.

[11] The curable composition according to any one of [1] to

[10] , wherein the ratio of the number of (meth)acryloyl groups (mmol / g) to the total number of polymerizable functional groups (mmol / g) in the curable composition is 2% or more.

[12] A cured product of the curable composition according to any one of [1] to

[11] .

[13] The cured product according to

[12] , wherein the softening point measured by thermomechanical analysis is 100°C or higher.

[14] The cured product according to

[12] or

[13] , wherein the refractive index is 1.55 or higher.

[15] The cured product according to any one of

[12] to

[14] , wherein the specific gravity is 1.20 or lower.

[16] An optical article comprising the cured product according to any one of

[12] to

[15] .

[17] A lens comprising the optical article according to

[16] .

[18] The lens according to

[17] , comprising: a lens substrate comprising the cured product; and a hard coat layer provided on at least one main surface of the lens substrate.

[19] Eyeglasses comprising the lens according to

[17] or

[18] .

Claims

1. A curable composition comprising at least one styrene compound selected from the group consisting of styrene and styrene derivatives, a fluorene group-containing compound represented by the following formula (I), and a hydroxyl group-containing (meth)acrylate: In the formula (I), R 31 and R 32 are each independently an alkyl group having 1 to 4 carbon atoms; R 33 and R 34 are each independently a hydrogen atom or a methyl group, X and Y are each independently a linear or branched alkylene group having 1 to 4 carbon atoms, Z 1 and Z 2 each independently represents an aromatic carbocyclic ring having 5 to 10 carbon atoms or an alkylene group having 1 to 4 carbon atoms; 3 and Z 4 are each independently an aromatic carbocyclic ring having 5 to 8 carbon atoms or an alkyl group having 1 to 4 carbon atoms; m+n is an integer of 0 to 20; and o+q and p+r are each an integer of 0 to 4.

2. The curable composition according to claim 1, wherein the hydroxyl group-containing (meth)acrylate comprises an epoxy di(meth)acrylate represented by the following formula (II): In the formula (II), R 35 , and R 36 are each independently a hydrogen atom or a methyl group, A and B are each independently a linear or branched alkylene group having 1 to 4 carbon atoms which may be substituted with a hydroxy group, and E is a group represented by the following formula: and p+q=0 to 20.

3. The curable composition according to claim 1, wherein the ratio M1 / M2 of the mass M1 of the fluorene group-containing compound to the mass M2 of the styrene compound is 0.10 or more and 1.0 or less.

4. The curable composition according to claim 1, wherein the proportion of the fluorene group-containing compound is 10% by mass or more and 50% by mass or less.

5. The curable composition according to claim 1, wherein the proportion of the hydroxyl group-containing (meth)acrylate is 1% by mass or more and 25% by mass or less.

6. The curable composition according to claim 1, wherein the proportion of the styrene compound is 10% by mass or more and 80% by mass or less.

7. The curable composition of claim 1 further comprising an ultraviolet absorber.

8. The curable composition according to claim 7, wherein the ultraviolet absorber has a peak in at least one of a wavelength region of 280 nm or more and less than 320 nm and a wavelength region of 320 nm or more and 360 nm or less.

9. The curable composition according to claim 1, further comprising a bisphenol (meth)acrylate compound represented by the following formula (III): In the formula (III), R 37 and R 38 each independently represents a hydrogen atom or a methyl group, and m+n=1 to 20.

10. The curable composition according to claim 9, wherein the proportion of the bisphenol (meth)acrylate compound is 0.1% by mass or more and 30% by mass or less.

11. The curable composition according to claim 1, wherein the ratio of the number of (meth)acryloyl groups (mmol / g) to the total number of polymerizable functional groups (mmol / g) in the curable composition is 2% or more.

12. A cured product of the curable composition according to claim 1.

13. The cured product according to claim 12, which has a softening point of 100°C or higher as determined by thermomechanical analysis.

14. The cured product according to claim 12, which has a refractive index of 1.55 or more.

15. The hardened product according to claim 12, having a specific gravity of 1.20 or less.

16. An optical article comprising the cured product according to claim 12.

17. A lens comprising the optical article of claim 16.

18. The lens according to claim 17, comprising: a lens substrate containing the cured product; and a hard coat layer provided on at least one of the main surfaces of the lens substrate.

19. Eyeglasses comprising the lens of claim 17.

Citation Information

Patent Citations

  • Photopolymerizable composition and its application

    JP2004269814A

  • Optical resin

    JP2008001777A

  • Radical curing composition for optical material for casting molding

    JP2012246382A

  • Radical-curable composition for optical material suitable for casting molding

    JP2012251032A

  • High-refractivity lens resin monomer material

    CN105175607A